The expression of the glucose transporter SLC2A1 (like other proteins belonging to the same family—see Supplementary Table S2) was significantly reduced in the TKS4 KO cells, suggesting that TKS4 plays a role in the signaling pathways that contribute to cancer progression. The gene discussed is SLC2A1; the disease is cancer.